Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…
Davis Polk advised the underwriters in connection with the $528 million SEC-registered offering of 16,000,000 shares of common stock of Grocery Outlet Holding Corp. by certain existing…
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $207 million public offering of common stock of Denali Therapeutics,…
Davis Polk advised the initial purchasers in connection with the Regulation S offering of $300 million principal amount of 8.750% senior notes due 2021 by RongXingDa Development (BVI)…
Davis Polk is advising Tencent in connection with its investment with Dragoneer in $250 million aggregate principal amount of convertible senior notes to be issued by Farfetch Limited, the…
Davis Polk advised a leading financial institution as sole lead arranger and bookrunner, and as administrative agent and refinancing term lender, in connection with a $693 million…
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…
Davis Polk is advising an ad hoc group of secured term lenders (the “Ad Hoc Group”) in connection with an out-of-court restructuring of Key Energy Services, Inc. (“Key Energy”) and its…
Davis Polk advised the joint bookrunners in connection with the equity offering by Minerva S.A. and VDQ Holdings S.A., a shareholder of Minerva, of common shares of Minerva for an aggregate…